Skip to main content
NewslettersWatchlist

Psychemedics(PMD-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.53
Day High2.67
Open:2.67
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Globe Newswire
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend
Globe Newswire
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.’s Retirement after More than 20 Years of Dedicated Service
Globe Newswire
Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend
Globe Newswire
Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results
Globe Newswire
Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role
Globe Newswire
Psychemedics Corporation Declares Cash Dividend
Globe Newswire
Psychemedics Corporation Reports Stronger Revenue, Operating Profit and Earnings Growth in Third Quarter 2021
Globe NewsWire
Psychemedics Corporation Reports Stronger Second Quarter 2021 Financial Results
Business Wire
Montana Advisors Writes Open Letter to Psychemedics
Globe NewsWire
Psychemedics Corporation Reports First Quarter 2021 Financial Results
Globe NewsWire
Psychemedics Corporation Reports Fourth Quarter and Full Year 2020 Financial Results
Globe NewsWire
Robyn C. Davis Joins Psychemedics Board of Directors
Globe NewsWire
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller
Globe NewsWire
Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
Globe NewsWire
Psychemedics Announces Third Quarter Results
Globe NewsWire
Psychemedics Announces Second Quarter Results
Globe NewsWire
Psychemedics Announces First Quarter Results
Globe NewsWire
Psychemedics Announces a “Vaping Panel” to Detect and Deter the Use of Marijuana, CBD and Nicotine

Profile

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.